ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OXF Oxford Technology 4 Venture Capital Trust Plc

34.00
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Technology 4 Venture Capital Trust Plc LSE:OXF London Ordinary Share GB00B01H4V84 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 34.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Oxford Tech 4 VCT Correction: Oxford Technology 4 Vct Plc : Half-yearly Report

26/10/2016 10:01am

UK Regulatory


 
TIDMOXF 
 
   This is a correction of the announcement from 11:00 19.10.2016 BST. 
Reason for the correction: 
 
   Correction to portfolio table. 
 
   The RNS concerning the Interim Accounts for Oxford Technology 4 VCT to 
31 August 2016, issued on 19 October, was missing the line for Dynamic 
Extractions in the portfolio table on page 3. 
 
   This RNS, issued on 26 October includes the missing line. 
 
   Oxford Technology 4 Venture Capital Trust Plc 
 
   Unaudited Half-Yearly Report 
 
   For the period 
 
   1 March 2016 to 31 August 2016 
 
   Financial Headlines 
 
 
 
 
                               6 Months Ended      Year Ended 
                                31 August 2016   29 February 2016 
Net Assets at Period End          GBP7.66m          GBP7.69m 
Net Asset Value per Share           66.5p             66.8p 
Cumulative Dividend per Share       37.0p             37.0p 
Total NAV Return per Share         103.5p            103.8p 
Share Price                         47.0p             52.0p 
Earnings per Share                 (0.3)p             20.6p 
 
 
   Castleton Technology - infrastructure solutions in the social housing, 
commercial and public sectors 
 
   Company Number: 5038854 
 
   Registered Address: The Magdalen Centre, Oxford Science Park, Oxford OX4 
4GA 
 
   Statement on behalf of the Board 
 
   I am pleased to present the unaudited results for the six month period 
ended 31 August 2016. 
 
   Results and dividends 
 
   The Company's net asset value (NAV) per share has reduced from 66.8p at 
29 February 2016 by 0.3p to 66.5p at 31 August 2016. No dividend was 
declared or paid in the period, and further dividends are likely to 
require further investee company exits. 
 
   Portfolio review 
 
   The new VCT rules have not prevented us from investing GBP320k to 
support our existing portfolio companies. We invested GBP202k in Plasma 
Antennas to position them for a further funding round. GBP98k was 
invested in ImmBio at attractive terms at the end of their successful 
trials. Finally we invested GBP20k in Zuvasyntha to allow the company to 
reduce its cost base whilst pursuing strategic partnerships. 
 
   The Directors have reviewed the valuations of each investee company in 
the unquoted portfolio but have made only minor changes. Several 
companies in the portfolio have had minor valuation increases in the 
period to reflect their continued growth.  However this was more than 
offset by the fall in the Castleton Technologies share price from 78.5p 
on 29 February 2016 to 64.5p on 31 August 2016. 
 
   The Directors continue to take an active interest in the investee 
companies and look forward to continuing to work with OTM to maximise 
shareholder value and to secure profitable exits from these investee 
companies at the appropriate time and to enable further dividends to be 
paid. 
 
   Liquidity 
 
   At period end our Company had net current assets of GBP715k. This 
provides sufficient resource to match the expected short term support 
required for the portfolio. 
 
   VCT qualifying status 
 
   The Board has procedures in place to ensure that the Company continues 
to comply with the conditions laid down by HMRC for maintaining approval 
as a VCT. 
 
   Presentation of half-yearly report 
 
   In order to reduce the length of this report, we have omitted details of 
the Company's objectives and investment strategy, its Advisers and 
Registrars and how to buy and sell shares in the Company. These details 
are all included in the Annual Reports, which, together with previous 
half-yearly reports, are available for viewing on the Oxford Technology 
website. 
 
   Outlook 
 
   The last six months has seen a number of changes to qualification 
conditions for VCTs. However, as we are not looking to invest in new 
companies we do not believe that these changes will give rise to any 
issues for our Company. Likewise any uncertainties surrounding the 
departure from the EU are unlikely to affect us directly. The company 
continues to have a diversified portfolio with several promising 
companies capable of delivering very strong returns, and the board is 
focused on ensuring such realisations occur in a timely and appropriate 
fashion. 
 
   We were pleased to welcome a large number of shareholders to our AGM in 
July and I would like to take this opportunity to thank shareholders for 
their continued support.  One of our investees Plasma Antennas presented 
at the AGM, and their presentation is available on the Oxford Technology 
website. 
 
   On behalf of the Board 
 
   David Livesley 
 
   Chairman 
 
   19 October 2016 
 
   Investment Portfolio as at 31 August 2016 
 
 
 
 
                                                                                      Change 
                                                                                        in 
                                                                                       value 
                                                Net Cost                              for the 
                                                   of                                 6 month 
                                               investment  Carrying value at 31/8/16  period   % Equity held  % Equity held              % 
Company                Description              GBP'000             GBP'000           GBP'000       OT4           All OT      of fund investment value 
Castleton Technology   Mobile software for 
 (bid price 64.0p)      contractors                   192                      1,486    (325)            2.9            2.9                       21.4 
Glide Technologies     Needle free injector           975                      1,439        -            5.8            9.0                       20.7 
Select Technology      Photocopier interfaces         237                        960       19           18.4           58.5                       13.8 
Plasma Antennas        Directional antennas           650                        687      260           26.1           45.1                        9.9 
Diamond Hard Surfaces  Diamond coatings               640                        551      166           49.9           49.9                        7.9 
Arecor                 Protein stabilisation          291                        535       89            6.2            7.3                        7.7 
ImmBio                 Novel vaccines                 673                        448       98            8.3           13.9                        6.4 
Dynamic Extractions    Separation technology          377                        313        -           30.4           30.4                        4.5 
Oxis Energy            Rechargeable batteries         305                        183       33            0.3            0.5                        2.6 
Zuvasyntha             Microbial technology           333                        110       20           23.1           23.1                        1.6 
                       Bioengineering & 
Novacta                 antibiotics                   347                         63        -            2.4            2.4                        0.9 
Insense                Wound healing                  476                         48        -            4.5           12.1                        0.7 
Abzena                 Protein based peptide 
 (bid price 41p)        drugs                          33                         39      (8)            0.1            0.3                        0.6 
Orthogem               Bone graft material            130                         35        -            3.3           14.6                        0.5 
Historic Futures       Traceability software          420                         32        -            6.2            6.2                        0.5 
                       Virtual product 
MirriAd Advertising     placement                       -                         15        -            0.3            0.3                        0.2 
                       Production of metal 
Metal Nanopowders       powders                        51                         10        -           16.7           36.7                        0.2 
                       Production of hard 
Superhard Materials     materials                       9                          5        -           18.2           40.0                        0.1 
Total Investments                                   6,139                      6,961      352                                                     100% 
Other Net Assets                                                                 701 
 
  Net Assets                                                          7,662 
 
 
   Responsibility Statement of the Directors in respect of the half-yearly 
report 
 
   We confirm that to the best of our knowledge: 
 
 
   -- the half-yearly financial statements have been prepared in accordance 
      with the statement "Interim Financial Reporting" issued by the Financial 
      Reporting Council; 
 
 
   -- the half-yearly report includes a fair review of the information required 
      by the Financial Services Authority Disclosure and Transparency Rules, 
      being: 
 
 
   -- an indication of the important events that have occurred during the first 
      six months of the financial year and their impact on the condensed set of 
      financial statements. 
 
   -- a description of the principal risks and uncertainties for the remaining 
      six months of the year. 
 
   -- a description of related party transactions that have taken place in the 
      first six months of the current financial year that may have materially 
      affected the financial position or performance of the Company during that 
      period and any changes in the related party transactions described in the 
      last annual report that could do so. 
 
 
   On behalf of the Board: 
 
   David Livesley 
 
   Chairman 
 
   19 October 2016 
 
   Income Statement 
 
 
 
 
              Six months to 31 Aug 2016  Six months to 31 Aug 2015   Year to 29 February 2016 
              Revenue  Capital   Total   Revenue  Capital   Total   Revenue  Capital   Total 
              GBP'000  GBP'000  GBP'000  GBP'000  GBP'000  GBP'000  GBP'000  GBP'000  GBP'000 
 
Gain on 
 disposal of 
 fixed asset 
 investments        -        2        2        -    1,328    1,328        -    1,049     1,049 
 
Gain/(loss) 
 on 
 valuation 
 of fixed 
 asset 
 investments        -       32       32        -      733      733        -    1,355     1,355 
 
Other income        -        -        -        3        -        3       94        -        94 
 
Investment 
 management 
 fees            (10)     (28)     (38)     (10)     (28)     (38)     (19)     (58)      (77) 
 
Other 
 expenses        (27)        -     (27)     (26)        -     (26)     (55)        -      (55) 
 
Return on 
 ordinary 
 activities 
 before tax      (37)        6     (31)     (33)    2,033    2,000       20    2,346     2,366 
 
Taxation on 
ordinary 
activities          -        -        -        -        -        -        -        -         - 
 
 
Return on 
 ordinary 
 activities 
 after tax       (37)        6     (31)     (33)    2,033    2,000       20    2,346     2,366 
 
Earnings per 
 share - 
 basic and 
 diluted       (0.3)p     0.0p   (0.3)p   (0.3)p    17.7p    17.4p     0.2p    20.4p     20.6p 
 
 
   -- The 'Total' column of this statement is the profit and loss account of 
      the Company; the supplementary Revenue return and Capital return columns 
      have been prepared under guidance published by the Association of 
      Investment Companies. 
 
 
   -- All revenue and capital items in the above statement derive from 
      continuing operations. 
 
 
   -- The accompanying notes are an integral part of the half-yearly report. 
 
 
   -- The Company has only one class of business and derives its income from 
      investments made in shares and securities and from bank and money market 
      funds. 
 
 
   The Company has no recognised gains or losses other than the results for 
the period as set out above. Accordingly a Statement of Comprehensive 
Income is not required. 
 
   Balance Sheet 
 
 
 
 
                                               As at 31 Aug      As at 31 Aug    As at 29 February 
                                                   2016              2015              2016 
                                             GBP'000  GBP'000  GBP'000  GBP'000  GBP'000  GBP'000 
 
Fixed asset investments *                               6,961             7,544              6,619 
Current assets: 
Debtors                                           18               320                26 
Creditors: 
Amounts falling due within one year             (32)              (41)              (36) 
Cash at Bank                                     729               697             1,111 
Net current assets                                        715               976              1,101 
 
Creditors: 
 Amounts falling due in more than one year               (14)              (41)               (27) 
Net assets                                              7,662             8,479              7,693 
 
Called up equity share capital                          1,152             1,152              1,152 
Share premium                                             813               813                813 
Unrealised capital reserve                                821               899                600 
Profit and Loss account reserve                         4,876             5,615              5,128 
Total equity shareholders' funds                        7,662             8,479              7,693 
 
Net asset value per share                               66.5p             73.6p              66.8p 
 
  * At fair value through profit and loss 
 
 
   Statement of Changes in Equity 
 
 
 
 
                              Share                               Profit & Loss 
              Share Capital  Premium  Unrealised Capital Reserve     Reserve      Total 
                 GBP'000     GBP'000            GBP'000              GBP'000      GBP'000 
As at 1 
 March 2015           1,152      813                         255          5,411     7,631 
Revenue 
 return on 
 ordinary 
 activities 
 after tax                -        -                           -           (33)      (33) 
Expenses 
 charged to 
 capital                  -        -                           -           (28)      (28) 
Current 
 period 
 gains on 
 disposal                 -        -                           -          1,328     1,328 
Current 
 period 
 gains on 
 fair value 
 of 
 investments              -        -                         733              -       733 
Prior years' 
 unrealised 
 gains now 
 realised                 -        -                        (89)             89         - 
Dividends 
 paid                     -        -                           -        (1,152)   (1,152) 
Balance as 
 at 31 
 August 
 2015                 1,152      813                         899          5,615     8,479 
 
As at 1 
 March 2015           1,152      813                         255          5,411     7,631 
Revenue 
 return on 
 ordinary 
 activities 
 after tax                -        -                           -             20        20 
Expenses 
 charged to 
 capital                  -        -                           -           (58)      (58) 
Current 
 period 
 gains on 
 disposal                 -        -                           -          1,049     1,049 
Current 
 period 
 gains on 
 fair value 
 of 
 investments              -        -                       1,355              -     1,355 
Prior years' 
 unrealised 
 gains now 
 realised                 -        -                       (654)            654         - 
Movement in 
 reserves                 -        -                       (356)            356         - 
Dividends 
 paid                     -        -                           -        (2,304)   (2,304) 
Balance as 
 at 29 
 February 
 2016                 1,152      813                         600          5,128     7,693 
 
As at 1 
 March 2016           1,152      813                         600          5,128     7,693 
Revenue 
 return on 
 ordinary 
 activities 
 after tax                -        -                           -           (37)      (37) 
Expenses 
 charged to 
 capital                  -        -                           -           (28)      (28) 
Current 
 period 
 gains on 
 disposal                 -        -                           -              2         2 
Current 
 period 
 gains on 
 fair value 
 of 
 investments              -        -                          32              -        32 
Prior years' 
 unrealised 
 losses now 
 realised                 -        -                         189          (189)         - 
Balance as 
 at 31 
 August 
 2016                 1,152      813                         821          4,876     7,662 
 
 
   Statement of Cash Flows 
 
 
 
 
                      Six months to 31   Six months to 31       Year to 29 
                          Aug 2016           Aug 2015         February 2016 
                           GBP'000            GBP'000            GBP'000 
Cash flows from 
operating 
activities 
Return on ordinary 
 activities before 
 tax                               (31)              2,000               2,366 
Adjustments for: 
(Increase)/decrease 
 in debtors                           1              (161)                 125 
Decrease/(increase) 
 in creditors                      (17)               (15)                (33) 
(Gain) on disposal 
 of fixed asset 
 investments                        (2)            (1,328)             (1,049) 
(Gain) on valuation 
 of fixed asset 
 investments                       (32)              (733)             (1,355) 
Net cash generated 
 from operating 
 activities                        (81)              (237)                  54 
Cash flows from 
investing 
activities 
 
Purchase of fixed 
 asset investments                (320)              (200)               (645) 
Sale of fixed asset 
 investments                         19              1,577               3,297 
Total cash flows 
 from investing 
 activities                       (301)              1,377               2,652 
 
Cash flows from 
financing 
activities 
 
Dividends paid                        -            (1,152)             (2,304) 
Total cash flows 
 from financing 
 activities                           -            (1,152)             (2,304) 
 
Increase/Decrease in 
 cash and cash 
 equivalents                      (382)               (12)                 402 
 
Opening cash and 
 cash equivalents                 1,111                709                 709 
 
Closing cash and 
 cash equivalents                   729                697               1,111 
 
 
 
 
   Notes to the Half-Yearly Report 
 
   1.         Basis of preparation 
 
   The unaudited half-yearly results which cover the six months to 31 
August 2016 have been prepared in accordance with the Financial 
Reporting Council's (FRC) Financial Reporting Standard 104 Interim 
Financial Reporting ('FRS 104') and the Statement of Recommended 
Practice (SORP) for Investment Companies re-issued by the Association of 
Investment Companies in November 2014. Details of the accounting 
policies and valuation methodologies are included in the Annual Report. 
 
   2.         Publication of non-statutory accounts 
 
   The unaudited half-yearly results for the six months ended 31 August 
2016 do not constitute statutory accounts within the meaning of Section 
415 of the Companies Act 2006. The comparative figures for the year 
ended 29 February 2016 have been extracted from the audited financial 
statements for that year, which have been delivered to the Registrar of 
Companies. The independent auditor's report on those financial 
statements, in accordance with chapter 3, part 16 of the Companies Act 
2006, was unqualified. This half-yearly report has not been reviewed by 
the Company's auditor. 
 
   3.         Earnings per share 
 
   The calculation of earnings per share for the period is based on the 
return attributable to shareholders divided by the weighted average 
number of shares in issue during the period. There are no potentially 
dilutive capital instruments in issue and, therefore, no diluted returns 
per share figures are relevant. 
 
   4.         Net asset value per share 
 
   The net asset value per share is based on the net assets at the period 
end divided by the number of shares in issue at that date (11,516,946 in 
each case). 
 
   5.         Principal risks and uncertainties 
 
   The Company's assets consist of equity and fixed interest investments, 
cash and liquid resources. Its principal risks are therefore market risk, 
credit risk and liquidity risk. Other risks faced by the Company include 
economic, loss of approval as a Venture Capital Trust, investment and 
strategic, regulatory, reputational, operational and financial risks. 
These risks, and the way in which they are managed, are described in 
more detail in the Company's Annual Report and Accounts for the year 
ended 29 February 2016. The Company's principal risks and uncertainties 
have not changed materially since the date of that report. 
 
   6.         Related party transactions 
 
   OT4 Managers Ltd, a wholly owned subsidiary, provides investment 
management services to the Company for a fee of 1% of net assets per 
annum. 
 
   7.         Copies of this statement are available from Oxford Technology 
Management, The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA and 
on the Company's website - www.oxfordtechnology.com/vct4. 
 
   Board Directors: David Livesley, Alex Starling, Robin Goodfellow and 
Richard Roth. 
 
   Investment Manager: OT4 Managers Ltd with services contracted to Oxford 
Technology Management Ltd 
 
   Website: www.oxfordtechnology.com/vct4 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Oxford Technology 4 VCT plc via Globenewswire 
 
 
  http://www.oxfordtechnology.com 
 

(END) Dow Jones Newswires

October 26, 2016 05:01 ET (09:01 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.

1 Year Oxford Technology 4 Vent... Chart

1 Year Oxford Technology 4 Vent... Chart

1 Month Oxford Technology 4 Vent... Chart

1 Month Oxford Technology 4 Vent... Chart

Your Recent History

Delayed Upgrade Clock